Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,654.00    -60.00 (-3.50%)
Bid:
1,664.00
Ask:
1,678.00
Spread: 14.00 (0.841%)
Market Cap: £487.13m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

US DoD M53A1 Contract

26 Mar 2019 07:00

RNS Number : 9550T
Avon Rubber PLC
26 March 2019
 

26 March 2019

Avon Rubber p.l.c.

U.S. Department of Defense M53A1 mask and powered air system contract

 

Avon Rubber p.l.c. is pleased to announce that Avon Protection has been awarded a sole source contract to supply the U.S. Department of Defense ("DOD") with the M53A1 mask and powered air system and related accessories. The framework contract, which also covers additional Avon Protection products, including the ST54 self-contained breathing apparatus, has a maximum value of $246 million over a duration of up to 7 years, being a five-year base period plus two further one-year extension periods.

 

Avon Protection anticipates receiving the first order under this contract shortly, with deliveries expected to commence in the second half of the current 2019 financial year (ending 30 September 2019). As outlined in the Group's 2018 final results announcement, the first order will contribute to our expected Military revenues for the 2019 financial year.

 

Commenting, Paul McDonald, Chief Executive Officer, said:

 

"This is another significant, multi-year contract for Avon Protection and demonstrates our ongoing focus on technological excellence and innovation leadership as we continue to deliver against our growth strategy.

 

"Together with the M69 aircrew mask contract announced at the beginning of the year, this underpins our medium term outlook and provides good visibility of revenues going forward.

 

"We continue to pursue a number of other identified opportunities with the DOD and Rest of World Military customers, which give us further confidence in the Group's prospects."

 

For further enquiries, please contact:

 

Avon Rubber p.l.c.

Paul McDonald, Chief Executive Officer

01225 896 300

Nick Keveth, Chief Financial Officer

MHP Communications

Andrew Jaques

0203 128 8570

Charlie Barker

Pete Lambie

 

Legal Entity Identifier: 213800JM1AN62REBWA71

Note to editors: 

Avon Rubber is an innovative technology group which designs and produces specialist products and services to maximise the performance and capabilities of its customers. We specialise in Chemical, Biological, Radiological and Nuclear ("CBRN") and respiratory protection systems, as well as milking point solutions through our two businesses, Avon Protection and milkrite | InterPuls.

 

Avon Protection is the recognised global leader in advanced CBRN respiratory protection systems for the world's Military, Law Enforcement and Fire markets.

 

milkrite | InterPuls is a global leader providing complete milking point solutions to dairy farmers across the world with the aim of improving every farm it touches.

 

For further information, please visit our website: www.avon-rubber.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTDDGDXBDDBGCU
Date   Source Headline
9th Jun 20259:30 amRNSDirectors'/PDMR Shareholdings
5th Jun 20253:31 pmRNSUS Department of Defense Order
3rd Jun 20256:00 pmRNSRenewi
29th May 202510:00 amRNSHolding(s) in Company
21st May 20257:00 amRNSInterim Results
20th May 20254:00 pmRNSNotification of change in particulars of director
16th May 20253:00 pmRNSNotification of change in particulars of director
15th May 20251:00 pmRNSHolding(s) in Company
7th May 202510:00 amRNSDirectors'/PDMR Shareholding
6th May 202512:00 pmRNS-RNotice of Results & Investor Presentation via IMC
11th Apr 20254:00 pmRNSHolding(s) in Company
8th Apr 202511:00 amRNSDirectors'/PDMR Shareholding
27th Mar 20252:00 pmRNSHolding(s) in Company
26th Mar 20257:00 amRNSQ2 trading update
20th Mar 202510:00 amRNSHolding(s) in Company
11th Mar 20255:00 pmRNSDirector/PDMR Shareholding
6th Mar 20253:00 pmRNSDirectors'/PDMR Shareholdings
4th Mar 20254:00 pmRNSHolding(s) in Company
3rd Mar 20257:00 amRNSNext Generation IHPS Delivery Order
14th Feb 20252:00 pmRNSDirectors'/PDMR Shareholding
11th Feb 20254:00 pmRNSHolding(s) in Company
7th Feb 20254:00 pmRNSFinal Dividend Currency Exchange Rate
5th Feb 20254:00 pmRNSDirectors'/PDMR Shareholdings
31st Jan 202512:00 pmRNSResult of AGM
31st Jan 20257:00 amRNSAGM Statement
27th Jan 20253:00 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNSThales UK Contract Renewal
7th Jan 20259:00 amRNSDirectors'/PDMR Shareholding
6th Jan 20257:00 amRNSNext Generation IHPS Delivery Order
12th Dec 20242:00 pmRNSHolding in Company
10th Dec 20249:00 amRNSNotice of Annual Report & Accounts and AGM 2025
6th Dec 202411:00 amRNSDirectors'/PDMR Shareholding
28th Nov 20245:00 pmRNSDirector/PDMR Shareholding
19th Nov 20242:00 pmRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSPreliminary Results
6th Nov 20242:00 pmRNSHolding in Company
6th Nov 202410:00 amRNSDirectors'/PDMR Shareholding
25th Oct 202411:05 amRNSAppointment of Joint Corporate Broker
22nd Oct 20247:00 amRNSNotice of Results
8th Oct 202410:00 amRNSDirectors'/PDMR Shareholding
2nd Oct 20243:05 pmRNSHolding(s) in Company
26th Sep 20246:05 pmRNSHolding(s) in Company
10th Sep 20243:30 pmRNSDirector/PDMR Shareholding
15th Aug 20247:00 amRNSInterim Dividend Currency Exchange Rate
7th Aug 20249:00 amRNSDirectors'/PDMR Shareholdings
1st Aug 20248:19 amRNSChange of Company Name
1st Aug 20247:00 amRNSHolding(s) in Company
29th Jul 202412:00 pmRNSPDMR Shareholdings
25th Jul 20247:00 amRNSNew delivery order & updated FY 2024 guidance
10th Jul 20249:00 amRNSNotification of transaction of PDMR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.